Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 26 October 2009, doi:10.1136/bmj.b4037
Cite this as: BMJ 2009;339:b4037
A free lunch—not to be missed, but not effective as an incentive to complete treatment
| The first 150 words of the full text of this article appear below. |
In the linked randomised controlled trial (doi:10.1136/bmj.b4248), Martins and colleagues assess the effectiveness of a food incentive to enhance completion of treatment for tuberculosis in Timor-Leste. The meal, or "feijuada," was provided at health centres and comprised meat, beans, and vegetables with rice.1 It seems unlikely that anyone could describe the free lunch as anything but beneficial. Or could they? We need to know if the intervention is effective in achieving its desired purpose and what the opportunity costs may be before deciding if it is beneficial.
Although the success of treatment depends on treatment adherence, many patients do not follow their prescriptions and treatment recommendations.2 In the case of chronic communicable diseases such as tuberculosis and HIV infection, maximising adherence is crucial to optimising the outcomes of treatment not only for the individual but also for the community, through decreased transmission and risk of generation of drug
Dermot Maher, senior clinical epidemiologist
1 Medical Research Council/Uganda Virus Research Institute (MRC/UVRI) Uganda Research Unit on AIDS, PO Box 49 Entebbe, Uganda
dermot.maher@mrcuganda.org